发明授权
US5122468A Hut-78 cell lines infected with HTLV-III which secrete gp160
失效
Htt-78细胞株感染HTLV-III，分泌gp160
- 专利标题： Hut-78 cell lines infected with HTLV-III which secrete gp160
- 专利标题（中）： Htt-78细胞株感染HTLV-III，分泌gp160
-
申请号： US450884申请日： 1989-12-14
-
公开(公告)号： US5122468A公开(公告)日： 1992-06-16
- 发明人: Mangalasseril G. Sarngadharan , Vaniambadi S. Kalyanaraman
- 申请人： Mangalasseril G. Sarngadharan , Vaniambadi S. Kalyanaraman
- 申请人地址： NLX Arnhem
- 专利权人： Akzo N.V.
- 当前专利权人： Akzo N.V.
- 当前专利权人地址： NLX Arnhem
- 主分类号： C07K14/16
- IPC分类号： C07K14/16 ; G01N33/569
摘要：
Human Immunodeficiency Virus (HIV) glycoprotein gp160 is produced in its native form using a clone of HUT78 cells chronically infected with HTLV-III.sub.451, known as 6D5.sub.451, and grown in serum-free medium. gp160 is also produced in its native form using a clone of 6D5.sub.451 that contains no HTLV-III virus.
公开/授权文献
- US6156294A Composition and method for treatment of otitis media 公开/授权日：2000-12-05
信息查询
IPC分类:
